Prodrug Of green tea epigallocatechin-3-gallate (pro-EGCG) for use in the treatment of endometriosis

Chan, TH, Wang, CC
2018 · W7005116131
other OA: green CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy Full text JSON View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-09 ⓘ

This patent describes a prodrug of epigallocatechin-3-gallate (pro-EGCG) and its use in treating endometriosis by inhibiting inflammatory pathways.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text ⓘ

This patent describes a method of treating endometriosis and related indications by administering Pro-EGCG, a synthetic derivative of the green tea polyphenol epigallocatechin-3-gallate (EGCG). It claims Pro-EGCG use in the manufacture of a medicament intended for endometriosis treatment. The abstract provides no experimental study details, and does not explicitly state efficacy results or specific patient/population findings. This paper is centrally about endometriosis — it is a patent proposing Pro-EGCG as a therapeutic prodrug for treating endometriosis and related indications.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

US10188629; US10188629 B2; US10188629B2; US10,188,629; US10,188,629 B2; 10188629; Appl. No. 15/628001
Full text 1,236 characters · extracted from oa-html · click to expand
Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/76863 | Title: | Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) for use in the treatment of endometriosis | Authors: | Chan, TH Wang, CC | Issue Date: | 25-Jul-2017 | Source: | US Patent 9,713,603 B2. Washington, DC: US Patent and Trademark Office, 2017. | Abstract: | Method of treating endometriosis and related indications, comprising the administration of Pro-EGCG, a synthetic and derivative product of epigallocatechin-3-gallate [(-)-EGCG]. Use of Pro-EGCG in the manufacture of a medicament for treating endometriosis and related indications. Pro-EGCG for use in the treatment of endometriosis and related indications. | Rights: | Assignee: The Hong Kong Polytechnic University Assignee: The Chinese University of Hong Kong | | Appears in Collections: | Patent | Files in This Item: | File | Description | Size | Format | | |---|---|---|---|---| | us9713603b2.pdf | 1.55 MB | Adobe PDF | View/Open | Page views 141 Last Week 2 2 Last month Citations as of Apr 12, 2026 Downloads 124 Citations as of Apr 12, 2026 Google ScholarTM Check Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-11T07:17:55.795397+00:00
License: CC0 · commercial use OK